Once‐Daily Single‐Inhaler Triple versus Dual Therapy in Patients with COPD

By D. Lipson, F. Barnhart, N. Brealey, Jean Brooks, G. Criner, Nicola C. Day, M. Dransfield, D. Halpin, M. Han, Elaine C Jones and 8 more. New England Journal of Medicine, 2018

1,122 citations recorded by the source corpus.

Subfields: Physiology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/123f5f3c3caafb45a216ebf641b5e4d983e01764

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Physiology

1. J. Wedzicha
2. D. Parums

In Pulmonary and Respiratory Medicine

1. Jorgen Vestbo
2. A. Anzueto
3. Bartolome Celli
4. J. Wedzicha
5. R. Stockley
6. D. Parums
7. P. Barnes

Citations in the corpus

• Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary (2023, neutral): “107 On the”
• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019 (2019, methodology): “IMPACT also reported a different https://doi.org/10.1183/13993003.00164-2019 7 result to FLAME [34] for the comparison of double combinations, which can be attributed mainly to the different exacerbation risk of the study populations as already discussed.”